Department of Pathology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.
Department of Surgical Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.
Indian J Pathol Microbiol. 2023 Jul-Sep;66(3):444-448. doi: 10.4103/ijpm.ijpm_514_21.
Oral squamous cell carcinoma (OSCC) comprises more than 90% of oral cancers and is the most common carcinoma affecting the oral cavity. Early stage T1/T2 OSCC have a heterogeneous prognosis and a significant number of patients develop loco regional recurrence (LRR) and have reduced disease free survival (DFS) with increased disease related mortality.
To assess the impact of the three parameters used in Brandwein-Gensler risk model along with lympho-vascular invasion (LVI), depth of invasion (DOI) and lymph node metastases in predicting LRR in early stage OSCC.
This was a retrospective study on early stage T1/2 OSCC patients over a period of 2 years who received treatment by surgical resection and had follow-up data. LRR was assessed based on recurrence of OSCC at the initial site or in regional lymph nodes.
Out of 1135 OSCC cases during our study period a total of 207 cases befitted our inclusion criteria. Recurrence was noted in 113 (54.6%) cases. Univariate analysis identified LVI (P < 0.00001), DOI (P < 0.00001), nodal involvement (P < 0.00001), worst pattern of invasion (WPOI) (P < 0.00001), lymphocytic host response (LHR) (P = 0.004), perineural invasion (PNI) (P = 0.012) as strong statistically significant risk factors for LRR.
Adequate assessment of simple parameters on routine H and E by incorporating Brandwein-Gensler histological risk scoring model at the initial presentation can help prognosticate and predict LRR and select patients for post-surgical adjuvant therapy.
口腔鳞状细胞癌(OSCC)占口腔癌的 90%以上,是最常见的口腔癌。早期 T1/T2 OSCC 的预后存在异质性,许多患者会出现局部区域复发(LRR),无疾病生存率(DFS)降低,疾病相关死亡率增加。
评估 Brandwein-Gensler 风险模型中使用的三个参数以及淋巴管血管侵犯(LVI)、浸润深度(DOI)和淋巴结转移在预测早期 OSCC 局部区域复发(LRR)中的作用。
这是一项回顾性研究,纳入了在研究期间接受手术切除治疗且有随访数据的 2 年内早期 T1/2 OSCC 患者。根据 OSCC 初始部位或区域淋巴结的复发来评估 LRR。
在我们的研究期间,共发现 1135 例 OSCC 病例,其中 207 例符合纳入标准。113 例(54.6%)出现复发。单因素分析确定 LVI(P < 0.00001)、DOI(P < 0.00001)、淋巴结受累(P < 0.00001)、最差浸润模式(WPOI)(P < 0.00001)、淋巴细胞宿主反应(LHR)(P = 0.004)、神经周围侵犯(PNI)(P = 0.012)是 LRR 的强统计学显著危险因素。
在初始表现时,通过常规 H&E 评估简单参数并结合 Brandwein-Gensler 组织学风险评分模型,可充分评估 LRR 的预后和预测,并选择患者进行术后辅助治疗。